Theodosia Kalfa is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 206 publications with 4,953 citations (h-index 36); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3333 Burnet Ave
Ml 7015
Cincinnati, OH 452293039
Telephone
513-636-4266Registry record last updated 8 Jul 2007.
Clinical trials
- The Congenital Dyserythropoietic Anemia Registry (CDAR)
Sponsor: Children's Hospital Medical Center, Cincinnati
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year20251 payment
- Novo Nordisk ASProgram year20241 payment
- Novo Nordisk IncProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2008–2023 per NIH RePORTER. The latest:
- The Role of Erythroblastic Islands in Anemia of Inflammation
Cincinnati Childrens Hosp Med Ctr
FY2023$619,934R01HL152099 - The Role of Erythroblastic Islands in Anemia of Inflammation
Cincinnati Childrens Hosp Med Ctr
FY2022$619,934R01HL152099 - The Role of Erythroblastic Islands in Anemia of Inflammation
Cincinnati Childrens Hosp Med Ctr
FY2021$619,934R01HL152099
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease
Journal of Pharmacology and Experimental Therapeutics
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Rothenberg, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Andrew Redington
Cincinnati Children's Hospital Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”